T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia

Hepatology

Volumn 24, Issue 4 I, 1996, Pages 790-795

  Lechmann, Martin ^a   Ihlenfeldt, Hans Georg ^b   Braunschweiger, Ingrid ^a   Giers, Günther ^a   Jung, Günther ^b   Matz, Bertfried ^a   Kaiser, Rolf ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HEPATITIS C; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0029811057     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008855177     Document Type: Article

References (48)

1. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implication for diagnosis, development and control of viral disease. HEPATOLOGY 1991;14:381-388.
2. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989;244:359-362.
3. Choo Q-L, Weiner AJ, Overby LR, Kuo G, Houghton M. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990;46:423-441.
4. Alter HJ, Purcell RH, Shin JWJ, Melpolder C, Houghton M, Choo Q-L, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-1500.
5. Dienstag JL. Non-A non-B hepatitis: recognition, epidemiology, and clinical features. Gastroenterology 1983;85:439-462.
6. Dittmann S, Roggendorf M, Durkop J, Wiese M, Lorbeer B, Deinhardt F. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991;13:323-327.
7. Realdie G, Alberti A, Rugge M, Rigoli AM, Tremolada F, Schivazappa L, Ruol A. Long term follow-up of acute and chronic non-A, non-B posttransfusion hepatitis: evidence of progression to liver cirrhosis. Gut 1982;23:270-275.
8. Kiyosawa K, Sodemaya T, Tanaka E, Gibo Y, Yoshizawa K, Nakamo Y, Furuta S. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. HEPATOLOGY 1990;14:381-388.
9. Tsukuma H, Hiyama T, Tanak S, Nakao M, Yabuchi T, Kitamura T, Nakanishei K, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-1801.
10. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992;89:3468-3472.
11. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unumaaz D, Weiner AJ, Choo Q-L, et al. T-lymphocyte response to hepatitis C virus in clinical courses of infection. Gastroenterology 1993;104:580-587.
12. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, et al. T cell response to structural and nonstructural hepatitis C virus antigen in persistent and self-limited hepatitis C virus infections. HEPATOLOGY 1994;19:286-295.
13. Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, Follet EAC, et al. Mapping of serotype-specific, immonodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol 1993;31:1493-1503.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
15. Imberti L, Cariani E, Bettinardi A, Zonaro A, Albertini A, Primi D. An immunoassay for specific amplified HCV sequences. J Virol Methods 1991; 34:233-243.
16. King DS, Fields CG, Fields GB. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int J Peptide Protein Res 1990;36:255-266.
17. Shakil AO, Conry C, Alter HJ, Hayashi P, Kleiner DE, Tedeshi V, Kraczynski, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med 1995; 123:330-337.
18. + human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol 1984;33:754-757.
19. Cher DJ, Mosmann TR. Two types of murine helper T cell clones. II. Delayed-type hypersensitivity is mediated by TH 1 mediated clones. J Immunol 1987;138:3688.
20. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
21. Raff MC. Role of thymus-derived lymphocytes in the secondary humoral immune response in mice. Nature 1970;226:1257-1259.
22. Fleischer B, Becht H, Rott R. Recognition of viral antigens by human influenza A virus-specific T lymphocyte clones. J Immunol 1985;135:2800-2805.
23. + T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis. J Exp Med 1993;178:17-25.
24. Cassina F, Valentini P, Cataleta M, Manotti P, Francesconi R, Giostra F, Bianchi FB. Ultrasound-detected deep abdominal lymphnodes in chronic hepatitis C: high frequency and relationship with viremia [Abstract]. J Hepatol 1995;23(suppl 1):143.
25. Artini M, Natoli G, Avantaggiati ML, Balsano C, Chirillo P, Costanzo A, Bonavita MS, et al. Detection of replicative intermediates of viral RNA in peripheral blood mononuclear cells from chronic hepatitis C carriers. Arch Virol 1993;8:23-29.
26. Müller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L. Peripheral blood leukocytes serve as possible extrahepatic site for hepatitis C virus replication. J Gen Virol 1993;74:669-676.
27. Bouffard P, Hayashi H, Acevedo, Levy N, Zeldis JB. Hepatitis C is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis 1992;166:1276-1280.
28. Henin C, Makris M, Brown J, Peak IR, Preston EF. Peripheral mononuclear cells of haemophiliacs with chronic liver disease are infected with replicating hepatitis C virus. Brit J Haematol 1994;87:215-217.
29. O'Sullivan D, Arrhenius T, Sidney J, Del Guercio MF, Albertson M, Wall M, Oseroff C, et al. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. J Immunol 1991;147:2663-2669.
30. Falk K, Rötzschke O, Stevonić S, Jung G, Rammensee HG. Pool sequencing of natural HLA-DR, DQ and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 1994;39:230-242.
31. Rammensee HG, Friede T, StevonićS. MHC ligands and peptide motifs: first listing. Immunogenetics 1995;41:178-228.
32. Hammer J, Valsasnini P, Tolba K, Bolin D, Higelin J, Takacs B, Sinigaglia F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 1993;74:197-203.
33. Chicz RM, Urban RG, Gorga JC, Vignali DAA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993;178:27-47.
34. Kotwal GJ, Baroudy BM, Kuramoto IK, Mcdonald FF, Schiff GM, Holland PV, Zeldis JB. Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A 1992;9:4486-4489.
35. Okamoto H, Tsuda F, Machida A, Munekata E, Akahane Y, Sugai Y, Mashiko K, et al. Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis C virus infection. HEPATOLOGY 1992;15:180-186.
36. Sälberg M, Rudén U, Wahren B, Magnius LO. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site within the envelope 1 protein. Clin Exp Immunol 1993;91:489-494.
37. 7. Sälberg M, Pumpen P, Zhang ZX, Lundholm P, Gusars I, Rudén U, Wahren B, et al. Locations of antibody binding sites within conserved regions of the hepatitis C virus core protein. J Med Virol 1994;43:62-68.
38. Ishida C, Matsumoto K, Fukada K, Matsushita K, Shiraki H, Meada Y. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens. J Clin Microbiol 1993;31:936-940.
39. Nasoff MS, Zebedee SL, Inchauspe G, Prince AM. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci U S A 1991;88:5462-5466.
40. Koskinas J, McFarlane B, Nouri-Aria KT, Tibbs CJ, Mizokami M, Doaldson PT, McFarlane IG, et al. Cellular and humoral immune reaction against autoantigens and hepatitis C viral antigens in chronic hepatitis C. Gastroenterology 1994;107:1436-1442.
41. Milich DR, McLachlan A, Thornton GB, Hughes JL. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 1987;329:547-549.
42. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, Shearer GM. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4 cell numbers and clinical staging. J Clin Invest 1989; 84:1892-1899.
43. Lunardi-Iskandar Y, Nugeyre MT, Georgoulias V, Barre-Sinoussi F, Jasmin C, Chermann JC. Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells. J Clin Invest 1989;83:610-615.
44. Golding H, Shearer GM, Hillman K, Lucas P, Manischewitz J, Zajac RA, Clerici M, et al. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest 1989;83:1430-1435.
45. H2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
46. Kekow J, Wachsmann W, McCuctchan JA, Gross WL, Zachariah M, Carson DA, Lotz M. Transforming growth factor-β and suppression of humoral immune responses in HIV infection. J Clin Invest 1991;87:1010-1016.
47. + cells of human immunodeficiency virus-infected patients suppresses HLA-self restricted T-helper cell responses. Proc Natl Acad Sci U S A 1992;89: 8424-8429.
48. Castillo A, Prieto J, Fausto N. Transforming growth factors β1 and α1 in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991;324:933-940.